In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.

Source:http://linkedlifedata.com/resource/pubmed/id/19369326

Download in:

View as

General Info

PMID
19369326